Several works have shown that both central and peripheral leptin resistance may be associated with different pathophysiological conditions related to obesity, such as inflammation, insulin resistance, and cardiovascular diseases (hypertension, atherosclerosis, obesity, ischemic heart disease, and heart failure), as well as hyperlipidemia [28, 29]. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.